GSA Capital Partners LLP Invests $567,000 in HCA Healthcare, Inc. (NYSE:HCA)

GSA Capital Partners LLP bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 1,394 shares of the company’s stock, valued at approximately $567,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Waverton Investment Management Ltd increased its position in shares of HCA Healthcare by 12.7% in the third quarter. Waverton Investment Management Ltd now owns 159,382 shares of the company’s stock worth $64,767,000 after purchasing an additional 17,968 shares during the period. Nations Financial Group Inc. IA ADV bought a new position in shares of HCA Healthcare in the third quarter worth $325,000. Venturi Wealth Management LLC increased its position in shares of HCA Healthcare by 13.4% in the third quarter. Venturi Wealth Management LLC now owns 5,335 shares of the company’s stock worth $2,168,000 after purchasing an additional 629 shares during the period. Patten & Patten Inc. TN grew its position in HCA Healthcare by 4.4% in the third quarter. Patten & Patten Inc. TN now owns 14,380 shares of the company’s stock valued at $5,844,000 after acquiring an additional 610 shares during the last quarter. Finally, Ashton Thomas Securities LLC bought a new position in HCA Healthcare in the third quarter valued at about $103,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analysts Set New Price Targets

HCA has been the topic of a number of recent analyst reports. Wells Fargo & Company lifted their target price on HCA Healthcare from $395.00 to $400.00 and gave the company an “equal weight” rating in a research report on Wednesday, November 6th. KeyCorp decreased their target price on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research report on Monday, October 28th. Leerink Partners lifted their price target on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. UBS Group lifted their price objective on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research note on Wednesday, August 14th. Finally, Morgan Stanley started coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price objective on the stock. Five investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $385.00.

HCA Healthcare Price Performance

Shares of HCA opened at $335.11 on Wednesday. The firm has a market cap of $84.88 billion, a PE ratio of 15.05, a price-to-earnings-growth ratio of 1.32 and a beta of 1.68. HCA Healthcare, Inc. has a 52-week low of $245.03 and a 52-week high of $417.14. The business’s 50 day moving average price is $383.10 and its two-hundred day moving average price is $358.30. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.79%. HCA Healthcare’s dividend payout ratio is 11.85%.

Insider Activity

In related news, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This trade represents a 21.97 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,155 shares of company stock worth $5,608,990 over the last quarter. 1.70% of the stock is currently owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.